Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 4, 2018
Patent Application Number
15996140
Date Filed
June 1, 2018
Patent Citations Received
0
Patent Primary Examiner
Patent abstract
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotide molecules comprising an mRNA encoding an OX40L polypeptide. Also provided is a method for activating T cells or increasing the number of NK cells in a subject in need thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
